📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Tumor suppressor p53: from engaging DNA to target gene regulation. (2020)

First Author: Sammons MA

Attributed to: The development of bispecific antibodies to promote proapoptotic immunotherapy in pancreatic cancer funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1093/nar/gkaa666

PubMed Identifier: 32797160

Publication URI: http://europepmc.org/abstract/MED/32797160

Type: Journal Article/Review

Volume: 48

Parent Publication: Nucleic acids research

Issue: 16

ISSN: 0305-1048